Pillar Biosciences is the leader in Decision Medicine™, utilizing highly accurate and sensitive next-generation sequencing (NGS) testing technology to optimize selection of precision therapies for cancer patients. Their NGS testing solutions are powered by proprietary technologies, helping to localize testing, reduce costs, and improve access and efficiency for clinicians and patients globally.
Market
Cancer diagnostics and precision therapy selection